In 2023, the incidence of Tuberculosis (including HIV-positive cases) in Japan stood at a measurable level, indicating ongoing challenges in tackling the disease. The forecasted data from 2024 to 2028 shows a notable reduction in incidence across these years, reflecting significant public health efforts and improvements. Specifically, the year-on-year reduction rates are impressive, averaging a substantial five-year decline. The compound annual growth rate (CAGR) is significant, emphasizing a strong downward trajectory in tuberculosis cases.
Future trends to watch for include the impact of continued healthcare innovations and policies aimed at completely eradicating tuberculosis by 2028. Monitoring the sustainability of these gains and the success of interventions targeting HIV-positive populations will be vital for ensuring long-term success.
